Therapy with interferons in blood diseases.
We report the clinical experience gained with interferon treatment of B and T cell neoplasms, as well as of myeloproliferative and myelodysplastic syndromes.
D000970:Antineoplastic Agents / Q000627:therapeutic use; D002455:Cell Division / Q000187:drug effects; D002462:Cell Membrane / Q000187:drug effects; D004341:Drug Evaluation; D006402:Hematologic Diseases / Q000188:drug therapy*; D006801:Humans; D007372:Interferons / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D007694:Killer Cells, Natural / Q000187:drug effects; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy; D009101:Multiple Myeloma / Q000188:drug therapy; D009190:Myelodysplastic Syndromes / Q000188:drug therapy; D011994:Recombinant Proteins / Q000494:pharmacology / Q000627:therapeutic use
D000970:Antineoplastic Agents; D011994:Recombinant Proteins; D007372:Interferons